# Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction

> **NCT04610892** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 423 (actual)

## Conditions studied

- Coronary Heart Disease (CHD)

## Interventions

- **BIOLOGICAL:** MEDI6570
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04610892
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-04
- **Primary completion:** 2023-11-08
- **Final completion:** 2023-11-08
- **Target enrollment:** 423 (ACTUAL)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04610892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04610892, "Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04610892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*